Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor.

Source:http://linkedlifedata.com/resource/pubmed/id/18519795

Clin. Cancer Res. 2008 Jun 1 14 11 3607-16

Download in:

View as

General Info

PMID
18519795